Patent watch: EPO rejects reach through claims.
D015195:Drug Design; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005060:Europe; D006801:Humans; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*